Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Experience in the treatment of prostatic carcinoma with cyproterone acetate.

× No keyword cloud information.

13 in total

1. The ultrastructure of the accessory sex organs of the male rat. 7. The effect of an anti-androgenic compound, SK and F 22340.

Authors: K J Tveter; E Dahl
Journal: Urol Res Date: 1975

2. Prostatic carcinoma.

Authors: D Kirk
Journal: Br Med J (Clin Res Ed) Date: 1985-03-23

Review 3. Pharmacology and clinical use of antiandrogens: a short review.

Authors: F Neumann
Journal: Ir J Med Sci Date: 1982-03 Impact factor: 1.568

4. Abiraterone for the Treatment of Advanced Prostate Cancer.

Authors: Patrick M Forde; Emmanuel S Antonarakis
Journal: Int J Target Ther Cancer Date: 2012-09-01

5. 3H-cyproterone acetate: binding characteristics to human uterine progestagen receptors.

Authors: H J Grill; B Manz; W Elger; K Pollow
Journal: J Endocrinol Invest Date: 1985-04 Impact factor: 4.256

Review 6. Hormonal therapy for stage D cancer of the prostate.

Authors: M R Gudziak; A Y Smith
Journal: West J Med Date: 1994-04

7. Effects of cyproterone acetate and a long-acting LHRH analogue on serum lipoproteins in patients with carcinoma of the prostate.

Authors: R B Paisey; C Kadow; C Bolton; M Hartog; J C Gingell
Journal: J R Soc Med Date: 1986-04 Impact factor: 5.344

Review 8. Cyproterone. A review of its pharmacology and therapeutic efficacy in prostate cancer.

Authors: L B Barradell; D Faulds
Journal: Drugs Aging Date: 1994-07 Impact factor: 3.923

9. Phase II trial and pharmacokinetic assessment of intravenous melphalan in patients with advanced prostate cancer.

Authors: D C Smith; D I Jodrell; M J Egorin; R M Ambinder; E G Zuhowski; W Kreis; P G Ellis; D L Trump
Journal: Cancer Chemother Pharmacol Date: 1993 Impact factor: 3.333

10. Gestagens in the management of prostatic carcinoma.

Authors: Z Szendröi
Journal: Int Urol Nephrol Date: 1984 Impact factor: 2.370